Status:
COMPLETED
Immune Responses to COVID-19 Infection or Vaccination
Lead Sponsor:
Aditxt, Inc.
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The overall purpose of this observational cohort study is to characterize COVID-specific immune responses to SARS-CoV-2 exposure or COVID vaccination in a real-world setting. Participants will be aske...
Detailed Description
1. Background and Overview Aditxt, Inc, in collaboration with researchers at Stanford University, has laboratory-developed tests (LDTs) for simultaneously monitoring anti-SARS-COV2 antibodies (IgG, Ig...
Eligibility Criteria
Inclusion
- Willingness to participate
- 18 years and older
Exclusion
- Refusal or inability to provide informed consent
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
403 Patients enrolled
Trial Details
Trial ID
NCT05379478
Start Date
December 1 2020
End Date
December 1 2023
Last Update
August 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aditxt
Richmond, Virginia, United States, 23219